Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-004022

Options or other derivatives

  • PRESIDENT AND CEO acquired 410,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kintz Samuel · PRESIDENT AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-13 Grant or award : show line 1 in the form Stock Option (right to buy) +410,000 410,000 D
Loading xslF345X05/form4-02162024_010204.xml…